Trademarkia Logo

Canada

C$
Trademark Search in Canada
Distinkt Design

View On IC.GC.CA

Distinkt Design
SEARCHED

on 14 Feb 2025

Last Applicant/ Owned by

Distex Biotech Ventures Ltd.

5733 80 Ave SECalgary

ALBERTA

CA

T2C4S6

Serial Number

2291113 filed on 6th Nov 2023

Correspondent Address

JOHN R. SANCHE

(Burnet, Duckworth & Palmer LLP)2400, 525 - 8th Avenue SWCalgary

ALBERTA

CA

T2P1G1

Distinkt Design

Trademark usage description

cannabis for medical purposes; cocaine for medical purposes; dried cannabis buds for medical purposes; fungal medications; hashish for medical purpose Read More

Vienna Information

7 . 3 . 1

Doors, entrancesPortes, entrées

26 . 3 . 1

One triangleUn triangle

26 . 3 . 16

Triangles containing other figurative elementsTriangles contenant d'autres éléments figuratifs

26 . 3 . 24

Triangles with dark surfaces or parts of surfacesTriangles avec surface ou partie de la surface foncée

26 . 3 . 26

Triangles with cutout areasTriangles avec des zones découpées

26 . 4 . 1

SquaresCarrés

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 18

Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

26 . 4 . 26

Quadrilaterals with cutout areasQuadrilatères avec des zones découpées

Classification Information

Class [005]
Cannabis for medical purposes; cocaine for medical purposes; dried cannabis buds for medical purposes; fungal medications; hashish for medical purposes; medicated nasal spray preparations; medicated oral care gels; medicated throat sprays; nasal spray preparations; nasal sprays for medical purposes; neurological and psychological pharmaceutical preparations for the treatment of chemical dependency; neurological and psychological pharmaceutical preparations for the treatment of drug addictions; neurological and psychological pharmaceutical preparations for the treatment of eating disorders and addictions; neurological pharmaceutical preparations for the prevention and treatment of Alzheimer's, Huntington's disease, and cerebral palsy; nose drops for medical purposes; opioid antagonist pharmaceutical preparations; opium; opium alkaloid preparations; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of diseases and disorders of the musculo-skeletal system; pharmaceutical and biological preparations for medical use, namely, for use in oncology, hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of smoking habits and addictions; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment and prevention of migraines, headaches and pain; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of opioid addiction; pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for treating opioid overdoses; prescription synthetic narcotics; smoking cannabis for medical purposes; transdermal patches containing cannabis as a sleep aid; transdermal patches containing cannabis for maintaining general health and well being; transdermal patches containing cannabis for management of opioid addiction; transdermal patches containing cannabis for reducing stress and fatigue; transdermal patches containing cannabis for relaxation; transdermal patches containing cannabis for relieving anxiety; transdermal patches containing cannabis for relieving depression; transdermal patches containing cannabis for the relief of epilepsy; transdermal patches containing cannabis for the relief of pain; vaping cannabis for medical purposes

Classification kind code

12

Class [034]
Cannabis distillate; cannabis for recreational use, for smoking; cannabis for recreational use, for vaporizing; cannabis for smoking; cannabis-derived resins and oils for recreational use, for smoking; cannabis-derived resins and oils for recreational use, for vaporizing; dried cannabis

Classification kind code

12

Class [035]
Wholesale sales of cannabis

Classification kind code

12

Mark Details

Serial Number

2291113

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 14th Feb 2025		Search Recorded
Submitted for opposition 30
on 6th Nov 2023		Filed
Submitted for opposition 1
on 6th Nov 2023		Created
Submitted for opposition 31
on 6th Nov 2023		Formalized